Lessons of the COVID-19 Pandemic for the EU BioEconomy

This is a guest post from Susan Finston and Nigel Thompson The COVID-19 pandemic has highlighted the critical importance of the innovative biopharmaceutical industry as country after country went into (repeated) lock-down without recourse to vaccines or safe and effective therapies. Now in 2021, the increasing availability of a number of novel COVID-19 vaccines give […]